Special Issue "Helicobacter Pylori Infection"
Deadline for manuscript submissions: closed (15 November 2014)
Prof. Dr. Marina de Bernard (Website)
Venetian Institute of Molecular Medicine, Via Orus 2, Padova, Italy
Fax: +39 049 792 3250
Interests: host-pathogen interaction; bacterial toxins; bacterial immune modulating factors; Helicobacter pylori
The story of Helicobacter pylori, the bacterium that infects half of the world’s population, begins in 1893, when the Italian Giulio Bizzozero described spiral microorganisms in the stomach of dogs. Subsequently, two German scientists, Salomon and Krieniz, confirmed the observation by Bizzozero, but none of them suspected that the spiral-shaped bacterium would turn out to be the most widespread infectious agent. Despite this evidence, the scientific community remained convinced that no bacterial life was possible in the stomach. The dogma was broken in the early eighties of the last century by Warren and Marshall, who went on to win the Nobel prize in the 2005 for the definitive demonstration that Helicobacter pylori is responsible for gastritis and peptic ulcer. From this extraordinary finding, an explosion of research followed, aimed at defining the role of H. pylori and its virulence factors in sustaining not only gastric inflammation but also gastric malignancies. Furthermore, in the more recent past, several studies have posed the possibility that H. pylori infection may be beneficial for human health and this opened a new and intriguing line of research.
This Special Issue provides an Open Access opportunity to publish research work and review articles related to Helicobacter pylori infection, with the aim of offering a comprehensive collection of the current knowledge on a bug whose name continues to claim interest in science and medicine.
Prof. Dr. Marina de Bernard
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diseases is an international peer-reviewed Open Access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. For the first couple of issues the Article Processing Charge (APC) will be waived for well-prepared manuscripts. English correction and/or formatting fees of 250 CHF (Swiss Francs) will be charged in certain cases for those articles accepted for publication that require extensive additional formatting and/or English corrections.
- Helicobacter pylori
- virulence factors
- gastroduodenal diseases
- chronic infection
- Helicobacter and beneficial effect